Legend Biotech (LEGN) Cash & Current Investments (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Cash & Current Investments data on file, last reported at $286.7 million in Q4 2025.

• In Q4 2025, Cash & Current Investments changed 0.02% year-over-year to $286.7 million; the TTM figure through Dec 2025 stood at $286.7 million (changed 0.02% YoY), while the FY2025 annual figure was $286.7 million, changed 0.02% from the prior year.
• Cash & Current Investments climbed to $286.7 million in Q4 2025, from $278.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $1.4 billion in Q2 2023 and bottomed at $243.5 million in Q2 2024.
• A 5-year average of $647.4 million and a median of $457.5 million in 2021 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments soared 446.63% — and 2024, when it sank 82.84%.
• Year by year, Cash & Current Investments stood at $690.4 million in 2021, then jumped by 40.74% to $971.6 million in 2022, then surged by 31.57% to $1.3 billion in 2023, then slumped by 77.57% to $286.8 million in 2024, then slipped by 0.02% to $286.7 million in 2025.
• The last three Cash & Current Investments figures came in at $286.7 million (Q4 2025), $278.9 million (Q3 2025), and $266.7 million (Q2 2025), per Business Quant data.

Peer Comparison